Apeiron Investment Group Ltd. - Apr 22, 2022 Form 4 Insider Report for ATAI Life Sciences N.V. (ATAI)

Role
10%+ Owner
Signature
Apeiron Investment Group Ltd. By: /s/ Julien Hofer, Director
Stock symbol
ATAI
Transactions as of
Apr 22, 2022
Transactions value $
$297,805
Form type
4
Date filed
4/26/2022, 04:15 PM
Previous filing
May 3, 2022
Next filing
Apr 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATAI Common Shares Purchase $255K +52.8K +3.27% $4.83 1.67M Apr 22, 2022 By Apeiron Presight Capital Fund II, L.P. F1
transaction ATAI Common Shares Purchase $42.8K +8.96K +0.54% $4.78 1.68M Apr 25, 2022 By Apeiron Presight Capital Fund II, L.P. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The common shares were purchased in multiple transactions at prices ranging from $4.77 to $4.90 per share. The reporting persons undertake to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. The common shares were purchased in multiple transactions at prices ranging from $4.72 to $4.80 per share. The reporting persons undertake to provide the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.